PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
J Neurol Neurosurg Psychiatry. 1979 October; 42(10): 873–880.
PMCID: PMC490357

Sialidosis type 1: cherry red spot-myoclonus syndrome with sialidase deficiency and altered electrophoretic mobilities of some enzymes known to be glycoproteins. 1. Clinical findings.

Abstract

A family is described with three affected brothers, two of whom were examined, born to consanguineous parent, who in early adult life began to experience ataxia, intention myoclonus, and progressive visual failure. The brothers examined had cherry red spots at the maculae and cataracts. They were of normal intelligence. The intention myoclonus responded partially to treatment with clonazepam and pheneturide, but not to 5-hydroxytryptophan in combination with carbidopa or to sodium valproate. Studies in one patient showed the excretion of large quantities of sialylated oligosaccharides in the urine. Both patients showed deficient sialidase activity in their cultured fibroblasts. Further studies on cultured skin fibroblasts revealed increased electrophoretic mobility of six glycoprotein enzymes that was returned approximately to normal by treatment with sialidase. The clinical and biochemical findings indicate that these patients are further cases of the newly described condition sialidosis type 1.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Durand P, Gatti R, Cavalieri S, Borrone C, Tondeur M, Michalski JC, Strecker G. Sialidosis (mucolipidosis I). Helv Paediatr Acta. 1977 Nov;32(4-5):391–400. [PubMed]
  • Engel J, Jr, Rapin I, Giblin DR. Electrophysiological studies in two patients with cherry red spot--myoclonus syndrome. Epilepsia. 1977 Mar;18(1):73–87. [PubMed]
  • Goldstein ML, Kolodny EH, Gascon GG, Gilles FH. Macular cherry-red spot, myoclonic epilepsy, and neurovisceral storage in a 17-year-old girl. Trans Am Neurol Assoc. 1974;99:110–112. [PubMed]
  • Itoyama Y, Goto I, Kuroiwa Y, Takeichi M, Kawabuchi M, Tanaka Y. Familial juvenile neuronal storage disease. New disease or variant of juvenile lipidosis? Arch Neurol. 1978 Dec;35(12):792–800. [PubMed]
  • Johnson WG, Chutorian AB. Inheritance of the enzyme defect in a new hexosaminidase deficiency disease. Ann Neurol. 1978 Nov;4(5):399–403. [PubMed]
  • Johnson WG, Chutorian A, Miranda A. A new juvenile hexosaminidase deficiency disease presenting as cerebellar ataxia. Clinical and biochemical studies. Neurology. 1977 Nov;27(11):1012–1018. [PubMed]
  • Lowden JA, O'Brien JS. Sialidosis: a review of human neuraminidase deficiency. Am J Hum Genet. 1979 Jan;31(1):1–18. [PubMed]
  • O'Brien JS. Neuraminidase deficiency in the cherry red spot-myoclonus syndrome. Biochem Biophys Res Commun. 1977 Dec 21;79(4):1136–1141. [PubMed]
  • O'Brien JS. The cherry red spot-myoclonus syndrome: a newly recognized inherited lysosomal storage disease due to acid neuraminidase deficiency. Clin Genet. 1978 Jul;14(1):55–60. [PubMed]
  • Rapin I, Goldfischer S, Katzman R, Engel J, Jr, O'Brien JS. The cherry-red spot--myoclonus syndrome. Ann Neurol. 1978 Mar;3(3):234–242. [PubMed]
  • Strecker G, Hondi-Assah T, Fournet B, Spik G, Montreuil J, Maroteaux P, Durand P, Farriaux JP. Structure of the three major sialyl-oligosaccharides excreted in the urine of five patients with three distinct inborn diseases: "I cell disease" and two new types of mucolipidosis. Biochim Biophys Acta. 1976 Sep 24;444(2):349–358. [PubMed]
  • Strecker G, Peers MC, Michalski JC, Hondi-Assah T, Fournet B, Spik G, Montreuil J, Farriaux JP, Maroteaux P, Durand P. Structure of nine sialyl-oligosaccharides accumulated in urine of eleven patients with three different types of sialidosis. Mucolipidosis II and two new types of mucolipidosis. Eur J Biochem. 1977 May 16;75(2):391–403. [PubMed]
  • Swallow DM, Evans L, Stewart G, Thomas PK, Abrams JD. Sialidosis type 1: cherry red spot-myoclonus syndrome with sialidase deficiency and altered electrophoretic mobility of some enzymes known to be glycoproteins. II. Enzymes studies. Ann Hum Genet. 1979 Jul;43(1):27–35. [PubMed]
  • Thomas GH, Tipton RE, Ch'ien LT, Reynolds LW, Miller CS. Sialidase (alpha-n-acetyl neuraminidase) deficiency: the enzyme defect in an adult with macular cherry-red spots and myoclonus without dementia. Clin Genet. 1978 Apr;13(4):369–379. [PubMed]
  • Wenger DA, Tarby TJ, Wharton C. Macular cherry-red spots and myoclonus with dementia: coexistent neuraminidase and beta-galactosidase deficiencies. Biochem Biophys Res Commun. 1978 May 30;82(2):589–595. [PubMed]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Group